Platform
Features
Pricing
0 followers
Visus Therapeutics is a clinical-stage company in pursuit of developing the world’s first presbyopia-correcting eye drop with the potential to last at least eight hours.
Industries
Headquarters
Employees
Links
Ben Bergo
9 members
8 members
4 members
3 members
Vaxcyte
2 followers
Kyverna Therapeutics
7 followers
Slingshot Biosciences
1 follower
Priovant
A-Alpha Bio
Lisata Therapeutics
Thermo Fisher Scientific
182 followers
Genentech
163 followers
Gilead Sciences
136 followers
Biogen
123 followers
Regeneron
105 followers
Explore companies